AseBio and Alira Health announce Market Access Mentoring Program for 2024

  • The 2024 program application will open on January 25th and close on February 21st.
  • The 2024 edition format includes a 40-hour service package for three companies that includes an initial meeting, background analysis, tailored orientation session for market access and pricing, and gap analysis.
AseBio
Mentoring_AseBio_Alira_Health
Corporate

Following the success of the 2023 program, Alira Health, a global healthcare advisory and technology company, and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.

The 2024 edition is the second edition of the Market Access Mentoring Program by Alira Health and AseBio. The 2023 program, with the goal to promote access to innovation, was highly successful, with 100% of the participating biotech startups stating that they would recommend the program to others. 

Alira Health pairs its experienced market access consultants with small and medium-sized enterprises (SMEs) to improve their value proposition, help them navigate the ecosystem, and properly define their market access needs. 

The 2024 edition format includes a 40-hour service package for three companies that includes an initial meeting, background analysis, tailored orientation session for market access and pricing, and gap analysis.

The 2024 program application will open on January 25th and close on February 21st. All AseBio biotech SMEs are eligible to apply by completing the online application form candidates’ presentation will be held in March.

“We are delighted by the success of the AseBio mentoring program in 2023 and look forward to working with a new group of entrepreneurs in 2024. It’s all part of our commitment to boost biotech companies and strengthen innovation in Spain,” says Chus Castillo, Partner Consulting Iberia at Alira Health.

"We received very positive feedback from the first edition of the program. The participating companies highly valued the opportunity to work hand in hand with the Alira Health team, whose experience allowed them to identify where and how they can strengthen their products," says Ion Arocena, General Director of AseBio.

Contact information

Ángel Luis Jiménez
Head of Communication and Content
662 172 126
ajimenez@asebio.com

More information

AseBio brings together 300 entities and represents the entire Spanish biotechnology sector. Its mission is to lead the transformation of the country by positioning science, innovation, and especially biotechnology as drivers of economic growth and social well-being. Among its members are companies, associations, foundations, universities, technology centers, and research institutions that directly or indirectly engage in biotechnology-related activities in Spain.

Tags
AseBio